Now that we have approved disease-modifying therapies for Alzheimer’s disease (AD), what is the best way to work with patients, families, and colleagues to administer them?

Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-future-clinical-roadmap-anti-amyloid-therapies-2025a10007h0/1?ecd=bdc_podcast_libsyn_mscpedu